🇺🇸 FDA
Pipeline program

PREDNISONE , ABIRATERONE , MDV3100

9785-CL-0123

Phase 2 small_molecule active

Quick answer

PREDNISONE , ABIRATERONE , MDV3100 for Prostate Cancer is a Phase 2 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Astellas Pharma GmbH
Indication
Prostate Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials